Skip to main content

Peer Review reports

From: A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial

Original Submission
5 Mar 2021 Submitted Original manuscript
9 Mar 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
10 Mar 2021 Editorially accepted
13 Apr 2021 Article published 10.1186/s13063-021-05180-1

You can find further information about peer review here.

Back to article page